Tanzeum (albiglutide) Pen, Dosage, Price, Side Effects, Weight Loss, and PI for Type 2 Diabetes | Samar Borhani, PharmD | RxEconsult
Menus

All Health Articles

Tanzeum (albiglutide) Pen, Dosage, Price, Side Effects, Weight Loss Category: Diabetes by - May 28, 2014 | Views: 76131 | Likes: 3 | Comment: 0  

What is the dosage of Tanzeum Pen?

Tanzeum is supplied in two different dosages of 30 mg and 50 mg single dose pen. Each pen contains a powder that must be mixed with diluent prior to using. 

It is injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm. Initially, the recommended dose is 30 mg subcutaneously once a week with or without food. Depending on the blood glucose levels the dose may be increased to 50 mg once weekly if necessary. Tanzeum can be given at any time of the day but should be given on the same day of the week. Dose adjustment is not needed in patients with kidney problems.

What are side effects of Tanzeum?

Common: 

  • Nausea
  • Diarrhea
  • Injection site reactions
  • Upper respiratory tract infections
  • Cold and flu-like symptoms

Serious: 

  • Risk of Thyroid C-cell Tumors
  • Acute pancreatitis
  • Hypoglycemia
  • Serious hypersensitivity reactions
  • Renal impairment

What are Tanzeum drug interactions?

Tanzeum slows the movement of food and drugs through the stomach and intestines and, therefore, may reduce the absorption of oral drugs. Administration of oral drugs and Tanzeum should be separated. 

What is the price of Tanzeum?

The price of one 30 mg Tanzeum pen is about $113 and the price for 4 pens is $387 to $450 at local pharmacies. 

How to obtain prescription cost assistance for Tanzeum

Visit GlaxoSmithKline patient assistance programs.

Also Read

Tanzeum versus Victoza 

New Ways To Treat Type 2 Diabetes

New Standards For Diabetes Medical Care 

Measuring Blood Sugar Levels with a Continuous Glucose Monitor (CGM) 

Review of Insulin Types

List And Description Of Common Diabetes Symptoms And Risk Factors

Reference

Tanzeum prescribing information (PI). Wilmington, DE: GlaxoSmithKline LLC; 2014.

Written by Samar Borhani

Updated:2/26/15

 

 

 
 
 


For More Healthcare Insights Join Us On Twitter
and Facebook. Join The Community To Publish Articles.

Copyright 2024 RxEconsult. All Rights Reserved | Privacy Policy | Terms of Use | Sitemap